1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Idiopathic Intracranial Hypertension Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Acetazolamide 1.2.3 Methazolamide 1.2.4 Furosemide 1.2.5 Topiramate 1.2.6 Others 1.3 Market by Application 1.3.1 Global Idiopathic Intracranial Hypertension Treatment Market Share by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Ambulatory Surgery Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Idiopathic Intracranial Hypertension Treatment Market Perspective (2015-2026) 2.2 Global Idiopathic Intracranial Hypertension Treatment Growth Trends by Regions 2.2.1 Idiopathic Intracranial Hypertension Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Idiopathic Intracranial Hypertension Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Idiopathic Intracranial Hypertension Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Idiopathic Intracranial Hypertension Treatment Players by Market Size 3.1.1 Global Top Idiopathic Intracranial Hypertension Treatment Players by Revenue (2015-2020) 3.1.2 Global Idiopathic Intracranial Hypertension Treatment Revenue Market Share by Players (2015-2020) 3.2 Global Idiopathic Intracranial Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Idiopathic Intracranial Hypertension Treatment Revenue 3.4 Global Idiopathic Intracranial Hypertension Treatment Market Concentration Ratio 3.4.1 Global Idiopathic Intracranial Hypertension Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Intracranial Hypertension Treatment Revenue in 2019 3.5 Key Players Idiopathic Intracranial Hypertension Treatment Area Served 3.6 Key Players Idiopathic Intracranial Hypertension Treatment Product Solution and Service 3.7 Date of Enter into Idiopathic Intracranial Hypertension Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Idiopathic Intracranial Hypertension Treatment Breakdown Data by Type (2015-2026) 4.1 Global Idiopathic Intracranial Hypertension Treatment Historic Market Size by Type (2015-2020) 4.2 Global Idiopathic Intracranial Hypertension Treatment Forecasted Market Size by Type (2021-2026) 5 Idiopathic Intracranial Hypertension Treatment Breakdown Data by Application (2015-2026) 5.1 Global Idiopathic Intracranial Hypertension Treatment Historic Market Size by Application (2015-2020) 5.2 Global Idiopathic Intracranial Hypertension Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Idiopathic Intracranial Hypertension Treatment Market Size (2015-2026) 6.2 North America Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) 6.3 North America Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) 6.4 North America Idiopathic Intracranial Hypertension Treatment Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Idiopathic Intracranial Hypertension Treatment Market Size (2015-2026) 7.2 Europe Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) 7.3 Europe Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) 7.4 Europe Idiopathic Intracranial Hypertension Treatment Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Idiopathic Intracranial Hypertension Treatment Market Size (2015-2026) 8.2 China Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) 8.3 China Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) 8.4 China Idiopathic Intracranial Hypertension Treatment Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Idiopathic Intracranial Hypertension Treatment Market Size (2015-2026) 9.2 Japan Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) 9.3 Japan Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) 9.4 Japan Idiopathic Intracranial Hypertension Treatment Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size (2015-2026) 10.2 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) 10.3 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) 10.4 Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Avkare, Inc 11.1.1 Avkare, Inc Company Details 11.1.2 Avkare, Inc Business Overview 11.1.3 Avkare, Inc Idiopathic Intracranial Hypertension Treatment Introduction 11.1.4 Avkare, Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020)) 11.1.5 Avkare, Inc Recent Development 11.2 FDC 11.2.1 FDC Company Details 11.2.2 FDC Business Overview 11.2.3 FDC Idiopathic Intracranial Hypertension Treatment Introduction 11.2.4 FDC Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.2.5 FDC Recent Development 11.3 Heritage Pharmaceuticals Inc 11.3.1 Heritage Pharmaceuticals Inc Company Details 11.3.2 Heritage Pharmaceuticals Inc Business Overview 11.3.3 Heritage Pharmaceuticals Inc Idiopathic Intracranial Hypertension Treatment Introduction 11.3.4 Heritage Pharmaceuticals Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.3.5 Heritage Pharmaceuticals Inc Recent Development 11.4 Ingenus Pharmaceuticals 11.4.1 Ingenus Pharmaceuticals Company Details 11.4.2 Ingenus Pharmaceuticals Business Overview 11.4.3 Ingenus Pharmaceuticals Idiopathic Intracranial Hypertension Treatment Introduction 11.4.4 Ingenus Pharmaceuticals Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.4.5 Ingenus Pharmaceuticals Recent Development 11.5 Janssen - Cilag Pharmaceuticals SA 11.5.1 Janssen - Cilag Pharmaceuticals SA Company Details 11.5.2 Janssen - Cilag Pharmaceuticals SA Business Overview 11.5.3 Janssen - Cilag Pharmaceuticals SA Idiopathic Intracranial Hypertension Treatment Introduction 11.5.4 Janssen - Cilag Pharmaceuticals SA Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.5.5 Janssen - Cilag Pharmaceuticals SA Recent Development 11.6 Lannett Company, 11.6.1 Lannett Company, Company Details 11.6.2 Lannett Company, Business Overview 11.6.3 Lannett Company, Idiopathic Intracranial Hypertension Treatment Introduction 11.6.4 Lannett Company, Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.6.5 Lannett Company, Recent Development 11.7 Medtronic 11.7.1 Medtronic Company Details 11.7.2 Medtronic Business Overview 11.7.3 Medtronic Idiopathic Intracranial Hypertension Treatment Introduction 11.7.4 Medtronic Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.7.5 Medtronic Recent Development 11.8 MercuryPharma 11.8.1 MercuryPharma Company Details 11.8.2 MercuryPharma Business Overview 11.8.3 MercuryPharma Idiopathic Intracranial Hypertension Treatment Introduction 11.8.4 MercuryPharma Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.8.5 MercuryPharma Recent Development 11.9 Nostrum Laboratories Inc 11.9.1 Nostrum Laboratories Inc Company Details 11.9.2 Nostrum Laboratories Inc Business Overview 11.9.3 Nostrum Laboratories Inc Idiopathic Intracranial Hypertension Treatment Introduction 11.9.4 Nostrum Laboratories Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.9.5 Nostrum Laboratories Inc Recent Development 11.10 Novast Holdings Ltd. 11.10.1 Novast Holdings Ltd. Company Details 11.10.2 Novast Holdings Ltd. Business Overview 11.10.3 Novast Holdings Ltd. Idiopathic Intracranial Hypertension Treatment Introduction 11.10.4 Novast Holdings Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 11.10.5 Novast Holdings Ltd. Recent Development 11.11 Sanofi 10.11.1 Sanofi Company Details 10.11.2 Sanofi Business Overview 10.11.3 Sanofi Idiopathic Intracranial Hypertension Treatment Introduction 10.11.4 Sanofi Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.11.5 Sanofi Recent Development 11.12 SGPharma Pvt. Ltd. 10.12.1 SGPharma Pvt. Ltd. Company Details 10.12.2 SGPharma Pvt. Ltd. Business Overview 10.12.3 SGPharma Pvt. Ltd. Idiopathic Intracranial Hypertension Treatment Introduction 10.12.4 SGPharma Pvt. Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.12.5 SGPharma Pvt. Ltd. Recent Development 11.13 Sophysa 10.13.1 Sophysa Company Details 10.13.2 Sophysa Business Overview 10.13.3 Sophysa Idiopathic Intracranial Hypertension Treatment Introduction 10.13.4 Sophysa Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.13.5 Sophysa Recent Development 11.14 Taro Pharmaceutical Industries Ltd. 10.14.1 Taro Pharmaceutical Industries Ltd. Company Details 10.14.2 Taro Pharmaceutical Industries Ltd. Business Overview 10.14.3 Taro Pharmaceutical Industries Ltd. Idiopathic Intracranial Hypertension Treatment Introduction 10.14.4 Taro Pharmaceutical Industries Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.14.5 Taro Pharmaceutical Industries Ltd. Recent Development 11.15 Teva Pharmaceutical Industries Ltd 10.15.1 Teva Pharmaceutical Industries Ltd Company Details 10.15.2 Teva Pharmaceutical Industries Ltd Business Overview 10.15.3 Teva Pharmaceutical Industries Ltd Idiopathic Intracranial Hypertension Treatment Introduction 10.15.4 Teva Pharmaceutical Industries Ltd Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.15.5 Teva Pharmaceutical Industries Ltd Recent Development 11.16 West-Ward Pharmaceutical 10.16.1 West-Ward Pharmaceutical Company Details 10.16.2 West-Ward Pharmaceutical Business Overview 10.16.3 West-Ward Pharmaceutical Idiopathic Intracranial Hypertension Treatment Introduction 10.16.4 West-Ward Pharmaceutical Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.16.5 West-Ward Pharmaceutical Recent Development 11.17 Zydus Pharmaceuticals 10.17.1 Zydus Pharmaceuticals Company Details 10.17.2 Zydus Pharmaceuticals Business Overview 10.17.3 Zydus Pharmaceuticals Idiopathic Intracranial Hypertension Treatment Introduction 10.17.4 Zydus Pharmaceuticals Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) 10.17.5 Zydus Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Idiopathic Intracranial Hypertension Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Acetazolamide Table 4. Key Players of Methazolamide Table 5. Key Players of Furosemide Table 6. Key Players of Topiramate Table 7. Key Players of Others Table 8. Global Idiopathic Intracranial Hypertension Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Idiopathic Intracranial Hypertension Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Idiopathic Intracranial Hypertension Treatment Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions (2015-2020) Table 12. Global Idiopathic Intracranial Hypertension Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions (2021-2026) Table 14. Idiopathic Intracranial Hypertension Treatment Market Market Trends Table 15. Idiopathic Intracranial Hypertension Treatment Market Drivers Table 16. Idiopathic Intracranial Hypertension Treatment Market Challenges Table 17. Idiopathic Intracranial Hypertension Treatment Market Restraints Table 18. Global Idiopathic Intracranial Hypertension Treatment Revenue by Players (2015-2020) (US$ Million) Table 19. Global Idiopathic Intracranial Hypertension Treatment Market Share by Players (2015-2020) Table 20. Global Top Idiopathic Intracranial Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Intracranial Hypertension Treatment as of 2019) Table 21. Global Idiopathic Intracranial Hypertension Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Idiopathic Intracranial Hypertension Treatment Product Solution and Service Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) (US$ Million) Table 26. Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Type (2015-2020) Table 27. Global Idiopathic Intracranial Hypertension Treatment Revenue Market Share by Type (2021-2026) Table 28. Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Application (2015-2020) Table 29. Global Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) (US$ Million) Table 30. Global Idiopathic Intracranial Hypertension Treatment Market Size Share by Application (2021-2026) Table 31. North America Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) (US$ Million) Table 32. North America Idiopathic Intracranial Hypertension Treatment Market Share by Type (2015-2020) Table 33. North America Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) (US$ Million) Table 34. North America Idiopathic Intracranial Hypertension Treatment Market Share by Application (2015-2020) Table 35. North America Idiopathic Intracranial Hypertension Treatment Market Size by Country (US$ Million) (2015-2020) Table 36. North America Idiopathic Intracranial Hypertension Treatment Market Share by Country (2015-2020) Table 37. Europe Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) (US$ Million) Table 38. Europe Idiopathic Intracranial Hypertension Treatment Market Share by Type (2015-2020) Table 39. Europe Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) (US$ Million) Table 40. Europe Idiopathic Intracranial Hypertension Treatment Market Share by Application (2015-2020) Table 41. Europe Idiopathic Intracranial Hypertension Treatment Market Size by Country (US$ Million) (2015-2020) Table 42. Europe Idiopathic Intracranial Hypertension Treatment Market Share by Country (2015-2020) Table 43. China Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) (US$ Million) Table 44. China Idiopathic Intracranial Hypertension Treatment Market Share by Type (2015-2020) Table 45. China Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) (US$ Million) Table 46. China Idiopathic Intracranial Hypertension Treatment Market Share by Application (2015-2020) Table 47. China Idiopathic Intracranial Hypertension Treatment Market Size by Region (US$ Million) (2015-2020) Table 48. China Idiopathic Intracranial Hypertension Treatment Market Share by Region (2015-2020) Table 49. Japan Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) (US$ Million) Table 50. Japan Idiopathic Intracranial Hypertension Treatment Market Share by Type (2015-2020) Table 51. Japan Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) (US$ Million) Table 52. Japan Idiopathic Intracranial Hypertension Treatment Market Share by Application (2015-2020) Table 53. Japan Idiopathic Intracranial Hypertension Treatment Market Size by Country (US$ Million) (2015-2020) Table 54. Japan Idiopathic Intracranial Hypertension Treatment Market Share by Country (2015-2020) Table 55. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Type (2015-2020) (US$ Million) Table 56. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Share by Type (2015-2020) Table 57. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Application (2015-2020) (US$ Million) Table 58. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Share by Application (2015-2020) Table 59. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size by Country (US$ Million) (2015-2020) Table 60. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Share by Country (2015-2020) Table 61. Avkare, Inc Company Details Table 62. Avkare, Inc Business Overview Table 63. Avkare, Inc Product Table 64. Avkare, Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 65. Avkare, Inc Recent Development Table 66. FDC Company Details Table 67. FDC Business Overview Table 68. FDC Product Table 69. FDC Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 70. FDC Recent Development Table 71. Heritage Pharmaceuticals Inc Company Details Table 72. Heritage Pharmaceuticals Inc Business Overview Table 73. Heritage Pharmaceuticals Inc Product Table 74. Heritage Pharmaceuticals Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 75. Heritage Pharmaceuticals Inc Recent Development Table 76. Ingenus Pharmaceuticals Company Details Table 77. Ingenus Pharmaceuticals Business Overview Table 78. Ingenus Pharmaceuticals Product Table 79. Ingenus Pharmaceuticals Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 80. Ingenus Pharmaceuticals Recent Development Table 81. Janssen - Cilag Pharmaceuticals SA Company Details Table 82. Janssen - Cilag Pharmaceuticals SA Business Overview Table 83. Janssen - Cilag Pharmaceuticals SA Product Table 84. Janssen - Cilag Pharmaceuticals SA Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 85. Janssen - Cilag Pharmaceuticals SA Recent Development Table 86. Lannett Company, Company Details Table 87. Lannett Company, Business Overview Table 88. Lannett Company, Product Table 89. Lannett Company, Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 90. Lannett Company, Recent Development Table 91. Medtronic Company Details Table 92. Medtronic Business Overview Table 93. Medtronic Product Table 94. Medtronic Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 95. Medtronic Recent Development Table 96. MercuryPharma Business Overview Table 97. MercuryPharma Product Table 98. MercuryPharma Company Details Table 99. MercuryPharma Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 100. MercuryPharma Recent Development Table 101. Nostrum Laboratories Inc Company Details Table 102. Nostrum Laboratories Inc Business Overview Table 103. Nostrum Laboratories Inc Product Table 104. Nostrum Laboratories Inc Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 105. Nostrum Laboratories Inc Recent Development Table 106. Novast Holdings Ltd. Company Details Table 107. Novast Holdings Ltd. Business Overview Table 108. Novast Holdings Ltd. Product Table 109. Novast Holdings Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 110. Novast Holdings Ltd. Recent Development Table 111. Sanofi Company Details Table 112. Sanofi Business Overview Table 113. Sanofi Product Table 114. Sanofi Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 115. Sanofi Recent Development Table 116. SGPharma Pvt. Ltd. Company Details Table 117. SGPharma Pvt. Ltd. Business Overview Table 118. SGPharma Pvt. Ltd. Product Table 119. SGPharma Pvt. Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 120. SGPharma Pvt. Ltd. Recent Development Table 121. Sophysa Company Details Table 122. Sophysa Business Overview Table 123. Sophysa Product Table 124. Sophysa Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 125. Sophysa Recent Development Table 126. Taro Pharmaceutical Industries Ltd. Company Details Table 127. Taro Pharmaceutical Industries Ltd. Business Overview Table 128. Taro Pharmaceutical Industries Ltd. Product Table 129. Taro Pharmaceutical Industries Ltd. Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 130. Taro Pharmaceutical Industries Ltd. Recent Development Table 131. Teva Pharmaceutical Industries Ltd Company Details Table 132. Teva Pharmaceutical Industries Ltd Business Overview Table 133. Teva Pharmaceutical Industries Ltd Product Table 134. Teva Pharmaceutical Industries Ltd Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 135. Teva Pharmaceutical Industries Ltd Recent Development Table 136. West-Ward Pharmaceutical Company Details Table 137. West-Ward Pharmaceutical Business Overview Table 138. West-Ward Pharmaceutical Product Table 139. West-Ward Pharmaceutical Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 140. West-Ward Pharmaceutical Recent Development Table 141. Zydus Pharmaceuticals Company Details Table 142. Zydus Pharmaceuticals Business Overview Table 143. Zydus Pharmaceuticals Product Table 144. Zydus Pharmaceuticals Revenue in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) (US$ Million) Table 145. Zydus Pharmaceuticals Recent Development Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Global Idiopathic Intracranial Hypertension Treatment Market Share by Type: 2020 VS 2026 Figure 2. Acetazolamide Features Figure 3. Methazolamide Features Figure 4. Furosemide Features Figure 5. Topiramate Features Figure 6. Others Features Figure 7. Global Idiopathic Intracranial Hypertension Treatment Market Share by Application: 2020 VS 2026 Figure 8. Hospital Case Studies Figure 9. Clinics Case Studies Figure 10. Ambulatory Surgery Centers Case Studies Figure 11. Idiopathic Intracranial Hypertension Treatment Report Years Considered Figure 12. Global Idiopathic Intracranial Hypertension Treatment Market Size (US$ Million), YoY Growth 2015-2026 Figure 13. Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions: 2020 VS 2026 Figure 14. Global Idiopathic Intracranial Hypertension Treatment Market Share by Regions (2021-2026) Figure 15. Global Idiopathic Intracranial Hypertension Treatment Market Share by Players in 2019 Figure 16. Global Top Idiopathic Intracranial Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Idiopathic Intracranial Hypertension Treatment as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Idiopathic Intracranial Hypertension Treatment Revenue in 2019 Figure 18. North America Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. United States Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Canada Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Europe Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Asia-Pacific Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. China Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Japan Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. South Korea Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Southeast Asia Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. India Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Australia Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Rest of Asia-Pacific Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Latin America Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Mexico Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Brazil Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Middle East & Africa Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Turkey Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Saudi Arabia Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. UAE Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Rest of Middle East & Africa Idiopathic Intracranial Hypertension Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Avkare, Inc Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 46. FDC Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 47. Heritage Pharmaceuticals Inc Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 48. Ingenus Pharmaceuticals Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 49. Janssen - Cilag Pharmaceuticals SA Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 50. Lannett Company, Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 51. Medtronic Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 52. MercuryPharma Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 53. Nostrum Laboratories Inc Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 54. Novast Holdings Ltd. Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 55. Sanofi Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 56. SGPharma Pvt. Ltd. Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 57. Sophysa Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 58. Taro Pharmaceutical Industries Ltd. Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 59. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 60. West-Ward Pharmaceutical Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 61. Zydus Pharmaceuticals Revenue Growth Rate in Idiopathic Intracranial Hypertension Treatment Business (2015-2020) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Avkare, Inc FDC Heritage Pharmaceuticals Inc Ingenus Pharmaceuticals Janssen - Cilag Pharmaceuticals SA Lannett Company, Medtronic MercuryPharma Nostrum Laboratories Inc Novast Holdings Ltd. Sanofi SGPharma Pvt. Ltd. Sophysa Taro Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd West-Ward Pharmaceutical Zydus Pharmaceuticals